Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
URG101 in Interstitial Cystitis/Bladder Pain Syndrome
NCT02591199Phase 2Terminated
- Sponsor
- Urigen Pharmaceuticals, Inc.
- Start
- Sep 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of heparin + lidocaine in interstitial cystitis (IC), bladder pain syndrome (BPS), sponsored by Urigen Pharmaceuticals, Inc.. Started Sep 2015; status: terminated.
02
Drugs
heparin + lidocaine
03
Conditions
interstitial cystitis (IC)bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT02591199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02591199.